Cytomedix lands $35M for wound care products

Maryland-based Cytomedix secures a $35 million investment commitment from Deerfield Management Co. following an important reimbursement win from the Centers for Medicare & Medicaid Services.

Wound care therapies maker Cytomedix(OTC:CMXI) landed a $35 million investment commitment from Deerfield Management Co., to be handed down in 2 tranches.

Cytomedix Inc., Deerfield Management

News Well, Funding Roundup, Medicare, Reimbursement, Wound Therapy

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1pQ8gNc